Personalized neurorehabilitative precision medicine – from data to therapies

Personalized neurorehabilitative precision medicine – from data to therapies - MWKNeuroReha

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025132

Enrollment

500

Registered

2021-04-26

Start date

2020-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I61 I62

Interventions

Group 1: For each patient with acute stroke affecting one upper extremity, data is collected consisting of clinical tests to describe the impairment and the severity of stroke, structural and function

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 18 years stroke effecting the upper extremity FMA < 50 Written informed consent

Exclusion criteria

Exclusion criteria: Subject is not yet 18 year. Subject has an acute stroke not affecting one UE FMA over 50 Subject or caregiver does not understand the study and its procedures and gives no informed consent.

Design outcomes

Primary

Measure	Time frame
Changes of FMA of the opper extremity from acute phase to 90 days after stroke event	—

Secondary

Measure	Time frame
Changes in SS-QOL, mRS, BI and ARAT between acute phase and 90 days stroke event	—

Countries

Germany

Contacts

Public ContactUlf Ziemann

Neurologische Universitätsklinik und Hertie-Institut für Klinische Hirnforschung

NeuroReha@med.uni-tuebingen.de07071 29 82049

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026